Rubicon Organics (CSE:ROMJ,OTCQX:ROMJF) announced the preparation for the approval of a European Union Good Manufacturing Practices (EU-GMP) certification started at its facility in Delta, BC.
As quoted in the press release:
The EU-GMP certification is given to companies who demonstrate a high degree of precision and consistency in their manufacturing procedures, and is a requirement for the import of medical cannabis products into the European market.
Working with Q&C, GMP consultants who have extensive experience across cannabis and international pharmaceutical industries, the BC Facility recently completed a trial audit as the first step in ensuring the correct controls and compliance are in place for European sales.
“We expect access to EU-GMP certified organic cannabis will be a game changer for medical markets both locally and internationally,” said Jesse McConnell, Co-Founder and CEO of Rubicon Organics. “With Q&C supporting our process, we look forward to providing access to our extensive genetics and top-tier terpene profiles around the world.”